Daunorubicin (daunorubicin) — Uses, Dosage, Side Effects & Safety

Drug class: Antineoplastic (Anthracycline Antibiotic)

Overview

Daunorubicin is a chemotherapy medication used to treat certain types of cancer, primarily acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in both adults and children. It is often used in combination with other chemotherapy agents as part of a treatment regimen. Daunorubicin works by interfering with the growth and spread of cancer cells in the body. It belongs to the anthracycline class of antibiotics, which damage the DNA inside cancer cells, preventing them from multiplying. Patients should be aware that daunorubicin is given by intravenous infusion in a hospital or clinic setting under the supervision of a healthcare professional. It can cause significant side effects, including effects on the heart and blood cells, so regular monitoring is essential.

Therapeutic uses

• Acute Myeloid Leukemia
• Acute Lymphoblastic Leukemia
• Breast Cancer

Common side effects

• Cardiomyopathy
• Myelosuppression
• Nausea
• Vomiting
• Alopecia
• Stomatitis
• Diarrhea
• Reddish urine

Frequently Asked Questions about Daunorubicin

What types of cancer is daunorubicin used to treat?

Daunorubicin is primarily used to treat acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), often in combination with other chemotherapy drugs.

How does daunorubicin work?

Daunorubicin works by binding to DNA in cancer cells, blocking their ability to divide and grow. This leads to cell death and helps control the spread of leukemia.

What are the most serious risks of daunorubicin?

The most serious risks include heart damage (cardiotoxicity), severe bone marrow suppression, and tissue damage if the drug leaks outside the vein (extravasation).

Can daunorubicin cause hair loss?

Yes, temporary hair loss is a common side effect of daunorubicin. Hair usually grows back after treatment ends.

Is it safe to receive vaccines while on daunorubicin?

Live vaccines should be avoided during daunorubicin treatment due to weakened immune function. Inactivated vaccines may be considered with your doctor's guidance.

How is daunorubicin administered?

Daunorubicin is given as an intravenous infusion in a hospital or clinic, under the supervision of a healthcare professional.

What monitoring is required during daunorubicin therapy?

Regular blood tests, heart function tests (such as echocardiograms), and monitoring for signs of infection or bleeding are required throughout treatment.

Educational information only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.